Abstract:Background: Clostridioides difficile is a leading cause of nosocomial infectious diarrhea in developed countries, and it has a significant economic impact throughout the world. Early detection of the pathogen and its toxins is critical because early treatment significantly reduces infection-related morbidity, mortality, and medical cost. Surveillance of healthcare-associated infections (HAIs) is conducted using the NHSN standardized infection ratio (SIR). This metric allows comparison of a facility’s observed infection rate to a national benchmark. The SIR can be elevated due to both a lack of institutional criteria for stool submission and the use of highly sensitive but poorly specific testing as a standalone test for diagnosis. The SIR can be artificially elevated by inclusion of C difficile carriers rather than infected patients due to inappropriate testing and overly sensitive methods. We aimed to determine the impact of an institutional nursing-driven protocol for stool submission as well as 2-step testing on the SIR. Methods: Starting from the fourth quarter of 2018, we instituted a nursing protocol for initiation of C. difficile testing. If the patient had ≥3 soft, loose, or liquid stools in 24 hours within the first 3 days of admission, they were placed on contact precautions and an unformed stool sample was submitted for C. difficile nucleic acid amplification testing (NAAT). A positive result prompted further evaluation with a stool enzyme immunoassay toxin test for confirmation of active infection. From hospital day 4 onward, stricter criteria were implemented for testing for C. difficile infection. Data were extrapolated for calculation of a quarterly SIR. This value was then compared to retrospective SIR data from the first quarter of 2016 to the third quarter of 2018. Results: The quarterly total of hospital-onset C. difficile infections from the first quarter of 2016 to the third quarter of 2018 ranged from 24 to 39 incidents per quarter. After implementing the nursing-driven protocol and 2-step testing, the quarterly total of hospital onset C. difficile infections decreased to 5–6 per quarter. The SIR prior to initiation ranged from 0.66 to 1.37 and decreased to 0.306–0.386 after the nursing-driven protocol and 2-step testing were implemented. Conclusions: Implementation of both an institutional nursing-driven protocol for stool submission and a 2-step testing protocol reduced the number of quarterly hospital-onset C. difficile events as well as our facility’s quarterly SIR to below the national standard. Funding: None Disclosures: Ioana Chirca, University Hospital

Clostridium difficile Diagnostics in Long-Term Care Facilities

Diagnostic Guidance for C. difficile Infections

High Prevalence of Multistep Algorithms in Diagnostic Clostridioides difficile Laboratory Testing

Advances in diagnostic assays for Clostridioides difficile infection in adults

Diagnosis of Clostridioides difficile infection and impact of testing

Clostridioides difficile Infection: Diagnosis and Treatment Challenges

Assessment Of Clostridium Difficile Infections By Quantitative Detection Of Tcdb Toxin By Use Of A Real-Time Cell Analysis System

A-278 Prevalence of Clostridium Difficile in Long-Term Care Facilities Using BD Max Cdiff Molecular Assay

Laboratory diagnosis of Clostridioides dif f icile infection: guidelines and status of practice in Korea

C. difficile biomarkers, pathogenicity and detection

Clostridioides Difficile: A Concise Review of Best Practices and Updates

A Bundled Approach to Reduce Delayed Testing and Hospital-Acquired Cases of Clostridioides difficile Infection

Laboratory diagnosis of Clostridium difficile-associated diarrhoea: a plea for culture

699. Clinical Outcomes and Management of NAAT-Positive/Toxin-Negative Clostridium difficile Infection: A Systematic Review and Meta-Analysis

Impact of the Reverse Two-Step Algorithm for Clostridioides difficile Testing in the Microbiology Laboratory on Hospitalized Patients

Clostridioides difficile Infection: A Clinical Review of Pathogenesis, Clinical Considerations, and Treatment Strategies

High Incidence and Morbidity of Clostridium Difficile Infection among Hospitalized Patients with Inflammatory Bowel Disease: A Prospective Observational Cohort Study

Emerging Diagnostics in Clostridioides difficile Infection

A-286 Performance Evaluation of Molecular Clostridium Difficile Assay using BD MaxTM System

Impact of the Introduction of a Two-Step Laboratory Diagnostic Algorithm in the Incidence and Earlier Diagnosis of Clostridioides difficile Infection

Risk Factors for Clostridium Difficile Infection in Cirrhotic Patients.